FDA considers a substance to get "authorized for investigation as a new drug" whether it is the topic of the Investigational New Drug software (IND) that has gone into result. Under FDA’s restrictions (21 CFR 312.two), Unless of course a medical investigation meets the restricted conditions in that regulation, an http://juliustbceg.tribunablog.com/about-medical-cannabis-8408152